Abstract
Arsenic (As) is an abundant toxicant present in groundwater and soil in various parts of the world including eastern part of India. The epidemiological studies have shown that arsenic exposure is linked to developmental defects and miscarriage. Placenta is known to utilize vasculogenesis to develop its vasculature circulation. The effects of four different doses of sodium meta-arsenite (0, 10, 20, 75, and 150 ppm) were assessed on the vascular structure using two different in vivo models, i.e., Matrigel and chorioallantoic membrane (CAM) assay. For the Matrigel assay, mice were exposed to different doses of arsenic through drinking water for 1 month. Placenta and Matrigel plug (which was inserted on gestational day (GD 0.5)) were removed on GD 14. Similar arsenic concentration was used in CAM assay to observe the effect of vessel development in hen’s eggs. The CAM assay outcome evaluated by Angiosys software showed that arsenic exposure reduced the total and mean tubule length in all the arsenic-treated groups. The percentage tubule inhibition was declined significantly in 20, 75, and 150 ppm arsenic-treated groups as evaluated by ImageJ software. Analysis of the CAM outcome by both the image analysis software indicated the adverse effect of arsenic on the tubules. Further, a significant higher blood vessel density in 10 ppm and lower vessel density in 20, 75, and 150 ppm arsenic-exposed mice were also observed in Matrigel plug assay. The placental hypertrophy and dysplasia especially in the labyrinth zone (vasculature) were noted in placenta of arsenic-treated mice. The study indicated that higher arsenic exposures inhibited the angiogenesis which was dose-dependent in both CAM and Matrigel assay and altered structural morphology of placenta. However, no inhibition of blood vessels was noted at lower, i.e., 10 ppm of arsenic-treated group.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brooks PC, Silletti S, von Schalscha TL, Friedlander M, Cheresh DA (1998) Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 92:391–400
Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389–395
Chakraborti D, Rahman MM, Paul K, Sengupta MK, Chowdhury UK, Lodh D et al (2002) Arsenic calamity in India and Bangladesh sub-continent-whom to blame. Talanta 58:3–22
Hayden MR, Tyagi SC (2004) Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation. Cardiovasc Diabetol 3:1–16
Kamat CD, Green DE, Curilla S, Warnke L, Hamilton JW, Sturup S, Clark C, Ihnat MA (2005) Role of HIF signaling on tumorigenesis in response to chronic low-dose arsenic administration. Toxicol Sci 86:248–257
Kao YH et al (2003) Low concentrations of arsenic induce vascular endothelial growth factor and nitric oxide release and stimulate angiogenesis in vitro. Chem Res Toxicol 16:460–468
Le Ricousse-Roussanne S et al (2004) Ex vivo differentiated endothelial and smooth muscle cells from human cord blood progenitors home to the angiogenic tumor vasculature. Cardiovasc Res 62:176–184
Liu B, Pan SG, Dong XS, Qiao HQ, Jiang HC, Krissansen GW, Sun XY (2006) Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice. Cancer Sci 97:675–681
Milton AH et al (2005) Chronic arsenic exposure and adverse pregnancy outcomes in Bangladesh. Epidemiology 16:82–86
Roboz GJ et al (2000) Arsenic trioxide induces dose-and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis. Blood 96:1525–1530
Sheu JR, Fu CC, Tsai ML, Chung WJ (1998) Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor on antiangiogenesis and antitumor activities. Anticancer Res 18:4435–4441
Slevin M, Cao Y, Kitajewski J (2009) Welcome to journal of angiogenesis research. J Angiogenes Res 1:1-2 doi:10.1186/2040-2384-1-1
Soucy NV et al (2003) Arsenic stimulates angiogenesis and tumorigenesis in vivo. Toxicol Sci 76:271–279
Soucy NV, Mayka D, Klei LR, Nemec AA, Bauer JA, Barchowsky A (2005) Neovascularization and angiogenic gene expression following chronic arsenic exposure in mice. Cardiovasc Toxicol 5:29–41
Straub AC et al (2007) Low level arsenic promotes progressive inflammatory angiogenesis and liver blood vessel remodeling in mice. Toxicol Appl Pharmacol 222:327–336
Tseng CH et al (2003) Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. Toxicol letters 137:15–21
WHO (2016) Arsenic fact sheet no. 372 Updated June 2016 WHO (World Health Organisation)
Wu MM et al (2006) Effect of plasma homocysteine level and urinary monomethylarsonic acid on the risk of arsenic-associated carotid atherosclerosis. Toxicol Appl Pharmacol 216:168–175
Acknowledgements
The authors are thankful to the Department of Bio-technology (DBT), New Delhi, India for providing financial support in the form of research grant under north-east program (SK and RD). Zydus Research Centre, Ahmedabad for providing animals for the study, and the staff of the Reproductive and Cyto-Toxicology Department as well as animal house facility of National Institute of Occupational Health for their assistance.
Author information
Authors and Affiliations
Corresponding author
Additional information
Responsible editor: Philippe Garrigues
Rights and permissions
About this article
Cite this article
Patel, B., Das, R., Gautam, A. et al. Evaluation of vascular effect of arsenic using in vivo assays. Environ Sci Pollut Res 24, 15521–15527 (2017). https://doi.org/10.1007/s11356-017-9156-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11356-017-9156-5